Pharmacokinetics of prednisolone in children with nephrosis

P F Miller, C J Bowmer, J Wheeldon, J T Brocklebank, P F Miller, C J Bowmer, J Wheeldon, J T Brocklebank

Abstract

The pharmacokinetics of prednisolone given intravenously were studied in 11 children with relapsed steroid responsive nephrotic syndrome, and four control subjects. The clearance of both total and unbound drug was decreased in these children and the unbound fraction of the drug in plasma was significantly correlated with the degree of hypoalbuminaemia. We conclude that changes in the clearance of prednisolone and altered protein binding might account for some of the variability in both therapeutic responses and the incidence of toxicity in patients treated with standard dosage regimens.

References

    1. Lancet. 1971 Oct 9;2(7728):778-80
    1. J Pharm Sci. 1976 Jul;65(7):1006-10
    1. Clin Pharmacokinet. 1976;1(1):2-24
    1. J Pediatr. 1978 Aug;93(2):299-303
    1. Br J Clin Pharmacol. 1982 Nov;14(5):667-72
    1. J Chromatogr. 1982 Nov 12;232(2):406-12
    1. J Steroid Biochem. 1983 Feb;18(2):191-4
    1. J Pediatr. 1983 Oct;103(4):553-7
    1. Br J Clin Pharmacol. 1984 Apr;17(4):423-31
    1. J Pediatr. 1988 Jan;112(1):122-6
    1. Science. 1962 Mar 23;135(3508):1062-3

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel